Eam Global Investors LLC Amphastar Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$29.79 - $42.29 $1.29 Million - $1.83 Million	-43,197 Reduced 47.11%	48,505 $1.69 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $2.11 Million - $3.34 Million	91,702 New	91,702 $3.29 Million
Q1 2019 May 10, 2019	SELL	$19.46 - $25.28 $1.21 Million - $1.58 Million	-62,426 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$17.72 - $22.51 $1.11 Million - $1.41 Million	62,426 New	62,426 $1.24 Million

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.